Autoimmune vasculitis
We relieve inflammation of the vascular wall to restore normal blood circulation.
About the disease
Autoimmune vasculitis is inflammation of the vessel walls, in which the immune system attacks the body's own tissues. This impairs blood supply to organs, and the consequences depend on the size of the vessels affected. The goal of treatment is to quench the inflammation and restore normal blood flow.
We use T-cell immunotherapy that acts selectively on the cells sustaining inflammation of the vessel wall. The method is especially relevant in vasculitis with an unclear autoantigenic nature, when it is hard to find a specific target for standard treatment.
The important difference from the classic regimen is selectivity. Standard treatment often relies on high doses of steroids and cytostatics that suppress immunity entirely. Immunotherapy works precisely.
The method is used to control inflammatory activity and reduce the risk of flare-ups. It is built into the overall care plan alongside disease-modifying therapy.
The physician decides whether treatment is possible and how it is structured after assessing the type of vasculitis, disease activity, organ involvement, and examination results.
Reducing vessel inflammation
The method quenches inflammation of the vessel wall.
Restoring blood flow
Helps return normal blood supply to tissues.
Selective action
Precise action instead of total immunosuppression.
When the cause is unclear
Suitable for vasculitis with no established autoantigen.
Part of the overall plan
Combines with disease-modifying therapy.
T-cell vaccination
The method aims to stimulate immune reactions selectively directed at inactivating pathogenic autoimmune T-lymphocytes.
Collection and isolation
Autoaggressive T-lymphocytes — cells attacking the body's own tissues — are isolated from your blood.
Vaccine preparation
The isolated cells are processed and used to create a personalized T-cell vaccine.
Vaccination
Administering the vaccine triggers a regulatory immune response that selectively suppresses only the pathogenic cell clones.
Monitoring and support
Inflammatory activity decreases without suppressing general immunity; the course is adjusted based on dynamics.
Frequently asked questions
How does immunotherapy work in vasculitis?
The method acts selectively on the immune cells that sustain inflammation of the vessel wall. This helps quench inflammation and restore blood supply to tissues.
How selective is the method?
It works precisely on the cells that sustain the disease and does not suppress immunity entirely, unlike high doses of steroids and cytostatics.
In which vasculitis is the method especially appropriate?
In autoimmune vasculitis with an unclear autoantigenic nature, when there is no standard target for treatment. The physician assesses the specific situation.
Can the method be combined with disease-modifying therapy?
Yes. Immunotherapy is built into the overall care plan alongside disease-modifying treatment; it complements it.
How does the course of treatment go?
After a consultation and assessment of the type and activity of vasculitis, the physician builds an individual program. The method is tolerated more gently than long-term immunosuppression.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation can be held remotely.
Other directions
Multiple sclerosis
Selective inactivation of aggressive lymphocytes to protect the myelin sheath of nerve fibers.
Rheumatoid arthritis
Relief of joint inflammation and restoration of mobility without suppressing general immunity.
Scleroderma
Correction of the immune response to stop excessive collagen production and protect internal organs.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.